1. Home
  2. NUVL vs FND Comparison

NUVL vs FND Comparison

Compare NUVL & FND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

N/A

Current Price

$96.50

Market Cap

7.8B

Sector

Health Care

ML Signal

N/A

Logo Floor & Decor Holdings Inc.

FND

Floor & Decor Holdings Inc.

N/A

Current Price

$50.27

Market Cap

7.4B

ML Signal

N/A

Company Overview

Basic Information
Metric
NUVL
FND
Founded
2017
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
RETAIL: Building Materials
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
7.4B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
NUVL
FND
Price
$96.50
$50.27
Analyst Decision
Strong Buy
Buy
Analyst Count
15
16
Target Price
$135.33
$78.81
AVG Volume (30 Days)
449.1K
2.2M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1.05
EPS
N/A
1.92
Revenue
N/A
$4,684,088,000.00
Revenue This Year
N/A
$7.56
Revenue Next Year
$1,165.56
$7.78
P/E Ratio
N/A
$26.21
Revenue Growth
N/A
5.12
52 Week Low
$55.54
$49.87
52 Week High
$113.02
$92.41

Technical Indicators

Market Signals
Indicator
NUVL
FND
Relative Strength Index (RSI) 39.83 30.92
Support Level $73.71 N/A
Resistance Level $107.13 $64.23
Average True Range (ATR) 3.10 2.08
MACD -0.09 -0.23
Stochastic Oscillator 21.24 7.62

Price Performance

Historical Comparison
NUVL
FND

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About FND Floor & Decor Holdings Inc.

Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site. The company segments include retail segment and others.

Share on Social Networks: